Merck Shares Snap Losing Streak with Friday Gain

Apr 17, 2026 17:32 UTC

MRK

Short term

Merck & Co. saw its stock price rebound on Friday, ending a six-session decline. The pharmaceutical giant continues to maintain positive year-to-date momentum despite recent volatility.

Shares rose 2.17% to close at $117.97
Recovery follows a 6.27% decline over six sessions
S&P 500 gained 3.81% during Merck's recent slump
Year-to-date performance remains positive at 11.05%

Shares of Merck (NYSE: MRK) rebounded on Friday, closing up 2.17% at $117.97. The move effectively halted a six-day downward trend that had seen the stock underperform the broader market. Over the previous six trading sessions, Merck's shares declined by 6.27%. This slump occurred during a period of general market strength, as the S&P 500 Index climbed 3.81% over the same timeframe, highlighting a temporary divergence between the pharmaceutical leader and the wider index. Despite the recent short-term volatility, the company's overall performance for 2026 remains robust. Merck shares have advanced 11.05% since the start of the year, suggesting that long-term investor sentiment remains positive. The Friday recovery suggests a potential floor for the stock after a week of selling pressure. Market participants are now monitoring whether the equity can sustain this bounce and realign with the broader market's upward trajectory.